Two healthcare names on the move thanks to Barron's

BioScrip (BIOS +5.3%) gets an early pop following a big thumbs up from Oscar Schafer in the Barron's Roundtable over the weekend. Also gaining after getting picked by Schafer is ANI Pharmaceuticals (ANIP +6.3%).

Now alone in the market for its estrogen product, ANI has been able to boost prices, and - combined with the acquisition of 31 generic products from Teva Pharmaceutical - the company could earn more than $1 per share this year, rising to $2 over time. "The key is to grow the portfolio from seven drugs to more than 30, and buy additional drugs."

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs